Bgn - biglycan Gene

Also Known as BSPG1

Species: Rattus norvegicus

Gene Type: protein coding
Gene ID: 25181

Summary

Predicted to enable extracellular matrix binding activity and glycosaminoglycan binding activity. Involved in blood vessel remodeling. Predicted to be located in several cellular components, including cell surface; sarcolemma; and transport vesicle. Predicted to be active in extracellular space. Human ortholog(s) of this gene implicated in Meester-Loeys syndrome and X-linked spondyloepimetaphyseal dysplasia. Orthologous to human BGN (biglycan). [provided by Alliance of Genome Resources, Apr 2022]

Bgn Products (1)

mRNA Protein Name
NM_017087.1 NP_058783.1 biglycan precursor

Gene Ontology

  • Biological Process
Biological Process GO Annotation Evidence References Source
involved in blood vessel remodeling IEP
IEP: Inferred from expression pattern
11728008 RGD
EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern
Protein Preferred Names Protein Names

biglycan

  • PG-S1

  • Small proteoglycan I (biglycan), bone (BSPG1) (bone/cartilage proteclycan 1 precursor)

  • bone/cartilage proteclycan 1

  • bone/cartilage proteoglycan I

Related Agents

  • Pre-clinical Phase

Pre-clinical Phase

Bioactive Molecules (4)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-139162 BGN3 99.55% Unkown
HY-RS01489 BGN Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS18113 Bgn Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS24587 Bgn Rat Pre-designed siRNA Set A Pre-designed Set / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens Bgn NCBI NCBI:633